Fetal and neonatal alloimmune thrombocytopenia: A rare case report of prenatal treatment
Key Clinical Message Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare but serious condition. The first‐line antenatal management of FNAIT consists of weekly IVIG with or without corticosteroids, ideally starting before 16 weeks of gestation.
Main Authors: | Sonia Giouleka, Ioannis Tsakiridis, Fotios Zachomitros, Apostolos Mamopoulos, Ioannis Kalogiannidis, Apostolos Athanasiadis, Themistoklis Dagklis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.7806 |
Similar Items
-
Neonatal and fetal alloimmune thrombocytopenia
by: Ioana Emanuela Atanasescu, et al.
Published: (2022-06-01) -
Neonatal Alloimmune Thrombocytopenia
by: Melike Sezgin Evim, et al.
Published: (2011-08-01) -
Prenatal Diagnosis of Isolated Single Umbilical Artery: Incidence, Risk Factors and Impact on Pregnancy Outcomes
by: Antonios Siargkas, et al.
Published: (2023-06-01) -
A case report of neonatal alloimmune thrombocytopenia: The utility of platelet crossmatch studies in the diagnosis and management
by: H A Venkatesh, et al.
Published: (2019-01-01) -
ABO incompatibility: A cause for neonatal alloimmune thrombocytopenia
by: Ripal J Shah, et al.
Published: (2023-01-01)